Image

Project 3: ACHIEVE- CHD

Project 3: ACHIEVE- CHD

Recruiting
40-75 years
All
Phase N/A

Powered by AI

Overview

This project is part of the ACHIEVE GREATER (Addressing Cardiometabolic Health In Populations Through Early Prevention in the Great Lakes Region) Center (IRB 100221MP2A), the purpose of which is to reduce cardiometabolic health disparities and downstream Black-White lifespan inequality in two cities: Detroit, Michigan, and Cleveland, Ohio. The ACHIEVE GREATER Center will involve three separate but related projects that aim to mitigate health disparities in risk factor control for three chronic conditions, hypertension (HTN, Project 1), heart failure (HF, Project 2) and coronary heart disease (CHD, Project 3), which drive downstream lifespan inequality. All three projects will involve the use of Community Health Workers (CHWs) to deliver an evidence-based practice intervention program called PAL2. All three projects will also utilize the PAL2 Implementation Intervention (PAL2-II), which is a set of structured training and evaluation strategies designed to optimize CHW competence and adherence (i.e., fidelity) to the PAL2 intervention program. The present study is Project 3 of the ACHIEVE GREATER Center.

Eligibility

Inclusion Criteria:

  1. 40 to 75 years of age
  2. Self-identified as Black or African American
  3. Residence in the Cleveland Metro Area
  4. Must have at least two of the following risk factors identified at a UH health fair screenings, with one risk factor being with SBP, A1c, or LDL:
    1. BMI≥30 mg/dL
    2. History of smoking
    3. Elevated blood pressure defined as SBP>140 or DBP>80 mmHg
    4. HbA1c≥5.7%
    5. LDL≥130
  5. Able to complete a coronary artery calcium score test (CAC)
  6. Willing and able to consent
  7. Willing to have a UH provider and UH care
  8. Currently insured for standard of care procedures

Exclusion Criteria:

  1. Established documented cardiovascular disease (coronary artery disease, peripheral artery disease, myocardial infarction, stroke).
  2. Systolic blood pressure ≥ 180 mmHg or diastolic blood pressure ≥ 110 mmHg
  3. Lung disease requiring supplemental oxygen therapy
  4. Individuals receiving treatment for cancer related disease
  5. Pregnant or nursing mothers

Study details
    Coronary Heart Disease

NCT05918380

University Hospitals Cleveland Medical Center

23 July 2025

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.